Elijah Torres 
Hengrui Pharma will receive an upfront payment of $200 million and grant Merck & Co. the exclusive rights to develop, manufacture, and market the drug HRS-5346 worldwide, excluding China. MEXICO CITY (apro) – Merck & Co., a leading global pharmaceutical company, has reached an agreement with Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) to acquire, … Read more
The project builds on previous trials in Scotland and now operates as a mobile system with enhanced lighting and camera upgrades. KOFORIDUA, Ghana (AP).- Since 2002, Charles Owusu Aseku has traveled across Ghana and abroad seeking treatment for a large keloid on his neck. After two unsuccessful surgeries and a consultation-only visit to South Africa, … Read more
Cardiovascular diseases are the leading cause of death and health expenditure worldwide. MADRID (EUROPA PRESS) – A medication originally developed for diabetes treatment has shown promising results in improving outcomes for patients with aortic stenosis undergoing heart valve interventions, according to a clinical trial conducted by the National Center for Cardiovascular Research (CNIC) in collaboration … Read more
In recognition of World Colorectal Cancer Day on March 31, experts emphasize that an unhealthy lifestyle can increase the risk of developing this type of digestive tumor. MADRID (EUROPA PRESS) – The Digestive Tumor Treatment Group (TTD) highlighted the significance of understanding risk factors that can elevate the likelihood of developing colorectal tumors, such as … Read more
